CFC Albuterol Inhaler Phase-Out Urged By Nine Groups In Citizen Petition
Executive Summary
Removing CFC-containing albuterol metered-dose inhalers from the essential use list would increase certainty about medication supply while providing asthma patients an adequate transition period to non-CFC alternatives, professional and patient groups said in a citizen petition to FDA
You may also be interested in...
FDA 2004 Reg Agenda Includes CFC Albuterol Phase Out, Final Label Rule
FDA will begin the phase out of CFC-containing albuterol products during 2004, according to HHS' semiannual regulatory agenda published in the Dec. 22 Federal Register
FDA 2004 Reg Agenda Includes CFC Albuterol Phase Out, Final Label Rule
FDA will begin the phase out of CFC-containing albuterol products during 2004, according to HHS' semiannual regulatory agenda published in the Dec. 22 Federal Register
CFC-Containing Albuterol Phase-Out Review To Begin January 2003
FDA will begin the phase-out process for CFC-containing albuterol and beclomethasone products after Jan. 20, 2003, when its final rule on ozone-depleting substances goes into effect